Publications

  1. Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A. DPPX potassium channel antibody: Frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014 Oct 15.
    View PubMed
  2. McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J. The neurologic significance of celiac disease biomarkers. Neurology. 2014 Sep 26.
    View PubMed
  3. Pittock SJ, Lennon VA, Bakshi N, Shen L, McKeon A, Quach H, Briggs FB, Bernstein AL, Schaefer CA, Barcellos LF. Seroprevalence of Aquaporin-4-IgG in a Northern California Population Representative Cohort of Multiple Sclerosis. JAMA Neurol. 2014 Sep 01.
    View PubMed
  4. Flanagan EP, Saito YA, Lennon VA, McKeon A, Fealey RD, Szarka LA, Murray JA, Foxx-Orenstein AE, Fox JC, Pittock SJ. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil. 2014 Sep; 26(9):1285-97. Epub 2014 Jul 20.
    View PubMed
  5. Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF. Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol. 2014 Aug 1; 71(8):1025-9.
    View PubMed
  6. Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Lancet Neurol. 2014 Aug; 13(8):795-806. Epub 2014 Jul 06.
    View PubMed
  7. Horta ES, Lennon VA, Lachance DH, Jenkins SM, Smith CY, McKeon A, Klein C, Pittock SJ. Neural autoantibody clusters aid diagnosis of cancer. Clin Cancer Res. 2014 Jul 15; 20(14):3862-9. Epub 2014 May 15.
    View PubMed
  8. Flanagan EP, Leep Hunderfund AN, Kumar N, Murray JA, Krecke KN, Katz BS, Pittock SJ. Clinical reasoning: a 55-year-old man with weight loss, ataxia, and foot drop. Neurology. 2014 Jun 17; 82(24):e214-9.
    View PubMed
  9. Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Hydrocephalus in neuromyelitis optica. Neurology. 2014 May 20; 82(20):1841-3. Epub 2014 Apr 23.
    View PubMed
  10. Toledano M, Britton JW, McKeon A, Shin C, Lennon VA, Quek AM, So E, Worrell GA, Cascino GD, Klein CJ, Lagerlund TD, Wirrell EC, Nickels KC, Pittock SJ. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014 May 6; 82(18):1578-86. Epub 2014 Apr 04.
    View PubMed
  11. Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol. 2014 Apr; 71(4):495-8.
    View PubMed
  12. Braksick SA, Cutsforth-Gregory JK, Black DF, Weinshenker BG, Pittock SJ, Kantarci OH. Teaching neuroimages: MRI in advanced neuromyelitis optica. Neurology. 2014 Mar 25; 82(12):e101-2.
    View PubMed
  13. Jiao Y, Fryer JP, Lennon VA, McKeon A, Jenkins SM, Smith CY, Quek AM, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014 Jan; 71(1):48-54.
    View PubMed
  14. Kotsenas AL, Watson RE, Pittock SJ, Britton JW, Hoye SL, Quek AM, Shin C, Klein CJ. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol. 2014 Jan; 35(1):84-9. Epub 2013 Jul 18
    View PubMed
  15. Sandy S, Pittock SJ, Seemungal TAR, Ali A. Aquaporin-4 immuneglobulin G testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease. Neurology International. 2014; 6(3):40-2.
  16. Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Clinical/scientific notes. Neurology. 2014; 82(20):1841-3.
  17. Iorio R, Pittock SJ. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies. Clinical and Experimental Neuroimmunology. 2014; 5(2):175-87.
  18. Clardy SL, Lennon VA, Dalmau J, Pittock SJ, Jones HR Jr, Renaud DL, Harper CM Jr, Matsumoto JY, McKeon A. Childhood onset of stiff-man syndrome. JAMA Neurol. 2013 Dec; 70(12):1531-6.
    View PubMed
  19. Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc. 2013 Nov; 88(11):1204-12.
    View PubMed
  20. Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013 Oct 1; 81(14):1197-204. Epub 2013 Aug 30.
    View PubMed
  21. Jeffery OJ, Lennon VA, Pittock SJ, Gregory JK, Britton JW, McKeon A. GABAB receptor autoantibody frequency in service serologic evaluation. Neurology. 2013 Sep 3; 81(10):882-7. Epub 2013 Aug 07.
    View PubMed
  22. Toledano M, Siddiqui MA, Thompson CA, Garza I, Pittock SJ. Teaching NeuroImages: diagnostic utility of FDG-PET in neurolymphomatosis. Neurology. 2013 Jul 2; 81(1):e3.
    View PubMed
  23. Toledano M, Siddiqui MA, Thompson CA, Garza I, Pittock SJ. Diagnostic utility of FDG-PET in neurolymphomatosis. Neurology. 2013 Jul; 81(1):e3.
  24. Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013 Jun; 12(6):554-62. Epub 2013 Apr 26.
    View PubMed
  25. McKeon A, Lennon VA, LaChance DH, Klein CJ, Pittock SJ. Striational antibodies in a paraneoplastic context. Muscle Nerve. 2013 Apr; 47(4):585-7. Epub 2013 Mar 05.
    View PubMed
  26. O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A. Autoimmune chorea in adults. Neurology. 2013 Mar 19; 80(12):1133-44. Epub 2013 Feb 20.
    View PubMed
  27. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):240-5. Epub 2012 Dec 01.
    View PubMed
  28. Iorio R, Fryer JP, Hinson SR, Fallier-Becker P, Wolburg H, Pittock SJ, Lennon VA. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun. 2013 Feb; 40:21-7. Epub 2012 Aug 18.
    View PubMed
  29. Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler. 2013 Feb; 19(2):188-98. Epub 2012 Jun 26.
    View PubMed
  30. Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013 Feb; 70(2):229-34.
    View PubMed
  31. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013 Jan; 70(1):44-50.
    View PubMed
  32. Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012 Dec; 69(12):1598-607.
    View PubMed
  33. Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK Jr. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012 Nov; 46(5):823-7.
    View PubMed
  34. Miles SL, Niles RM, Pittock S, Vile R, Davies J, Winters JL, Abu-Yaghi NE, Grothey A, Siddiqui M, Kaur J, Hartmann L, Kalli KR, Pease L, Kravitz D, Markovic S, Pulido JS. A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. Retina. 2012 Oct; 32(9):1959-66.
    View PubMed
  35. Apiwattanakul M, Asawavichienjinda T, Pulkes T, Tantirittisak T, Hemachudha T, Horta ES, Jenkins SM, Pittock SJ. Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients. J Neurol Sci. 2012 Sep 15; 320(1-2):118-20. Epub 2012 Jul 24.
    View PubMed
  36. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology. 2012 Sep 11; 79(11):1136-44. Epub 2012 Aug 15.
    View PubMed
  37. Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, Costanzi C, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster EA, Pittock SJ. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol. 2012 Aug; 69(8):1039-43.
    View PubMed
  38. Tarula E, Ramkissoon S, Pittock S, Sheen VL. Progressive mental status changes and seizures with fluid attenuated inversion recovery (FLAIR) hyperintensity on brain MRI. J Clin Neurosci. 2012 Jun; 19(6):873, 924.
    View PubMed
  39. Eggers SD, Pittock SJ, Shepard NT, Habermann TM, Neff BA, Klebig RR. Positional periodic alternating vertical nystagmus with PCA-Tr antibodies in Hodgkin lymphoma. Neurology. 2012 May 29; 78(22):1800-2. Epub 2012 May 16.
    View PubMed
  40. Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012 May; 69(5):582-93.
    View PubMed
  41. Bunyan RF, Pittock SJ. Do not treat from CIS onset: evaluate disease course and prognosis first--yes. Mult Scler. 2012 Apr; 18(4):391-3.
    View PubMed
  42. Paz Soldan MM, Pittock SJ, Weigand SD, Yawn BP, Rodriguez M. Statin therapy and multiple sclerosis disability in a population-based cohort. Mult Scler. 2012 Mar; 18(3):358-63. Epub 2011 Sep 09.
    View PubMed
  43. Meeusen JW, Klein CJ, Pirko I, Haselkorn KE, Kryzer TJ, Pittock SJ, Lachance DH, Dyck PJ, Lennon VA. Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol. 2012 Mar; 71(3):417-26.
    View PubMed
  44. Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012 Feb 28; 78(9):665-71; discussion 669. Epub 2012 Feb 01.
    View PubMed
  45. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012 Feb; 69(2):230-8.
    View PubMed
  46. Storoni M, Pittock SJ, Weinshenker BG, Plant GT. Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage. J Neurol Sci. 2012 Jan 15; 312(1-2):21-5. Epub 2011 Sep 14.
    View PubMed
  47. Apiwattanakul M, Asawavichienjinda T, Pulkes T, Tantirittisak T, Hemachudha T, Horta ES, Jenkins SM, Pittock SJ. Erratum: Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients (Journal of the Neurological Sciences (2012) 320 (118-120)). J Neurol Sci. 2012; 323(1-2):273.
  48. Jaben EA, Pulido JS, Pittock S, Markovic S, Winters JL. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. J Clin Apher. 2011 Dec; 26(6):356-61. Epub 2011 Sep 5.
    View PubMed
  49. Caplan JP, Binius T, Lennon VA, Pittock SJ, Rao MS. Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics. 2011 Nov-Dec; 52(6):501-6. Epub 2011 Sep 22.
    View PubMed
  50. Iorio R, Lucchinetti CF, Lennon VA, Costanzi C, Hinson S, Weinshenker BG, Pittock SJ. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology. 2011 Oct 25; 77(17):1644-6. Epub 2011 Oct 12.
    View PubMed
  51. Klein CJ, Kimmel GW, Pittock SJ, Engelstad JE, Cunningham JM, Wu Y, Dyck PJ. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol. 2011 Oct; 68(10):1295-302.
    View PubMed
  52. McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011 Oct; 122(4):381-400. Epub 2011 Sep 22.
    View PubMed
  53. McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011 Oct; 68(10):1282-9. Epub 2011 Jun 13.
    View PubMed
  54. Somers KJ, Lennon VA, Rundell JR, Pittock SJ, Drubach DA, Trenerry MR, Lachance DH, Klein CJ, Aston PA, McKeon A. Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity. J Neuropsychiatry Clin Neurosci. 2011 Fall; 23(4):425-33.
    View PubMed
  55. Costanzi C, Matiello M, Lucchinetti CF, Weinshenker BG, Pittock SJ, Mandrekar J, Thapa P, McKeon A. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica. Neurology. 2011 Aug 16; 77(7):659-66. Epub 2011 Aug 3.
    View PubMed
  56. Rudzinski LA, Pittock SJ, McKeon A, Lennon VA, Britton JW. Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res. 2011 Aug; 95(3):255-62. Epub 2011 May 12.
    View PubMed
  57. Keegan BM, Krecke KN, Pittock SJ. Reply to Duprez et al. and List et al. regarding chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Brain. 2011 Aug; 134(Pt 8):e186. Epub 2011 Mar 08.
    View PubMed
  58. Flanagan EP, Lennon VA, Pittock SJ. Autoimmune myelopathies. Continuum. 2011 Aug; 17(4):776-99.
  59. Magana SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011 Jul; 68(7):870-8. Epub 2011 Mar 14.
    View PubMed
  60. Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B, Aksamit AJ, Pittock SJ. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011 Jun 14; 76(24):2089-95.
    View PubMed
  61. Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, Tippmann-Peikert M, Silber MH. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011 Jun; 68(6):733-8.
    View PubMed
  62. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56(5):1452-9. Epub 2010 Dec 23.
    View PubMed
  63. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011 Apr 5; 76(14):1229-37. Epub 2011 Mar 02.
    View PubMed
  64. Dhamija R, Renaud DL, Pittock SJ, McKeon A, Lachance DH, Nickels KC, Wirrell EC, Kuntz NL, King MD, Lennon VA. Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol. 2011 Apr; 44(4):275-81.
    View PubMed
  65. McKeon A, Pittock SJ, Lennon VA. CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology. 2011 Mar 22; 76(12):1108-10.
    View PubMed
  66. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. "Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images": Correction. Arch Neurol. 2011 Mar; 68(3):371.
  67. McKeon A, Lindell EP, Atkinson JL, Weinshenker BG, Piepgras DG, Pittock SJ. Pearls & oy-sters: clues for spinal dural arteriovenous fistulae. Neurology. 2011 Jan 18; 76(3):e10-2.
    View PubMed
  68. Rashtak S, Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol. 2011 Jan; 230(1-2):130-4. Epub 2010 Nov 06.
    View PubMed
  69. Popescu BF, Parisi JE, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010 Dec 7; 75(23):2103-9.
    View PubMed
  70. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, McKeon A, Carpenter AF, Miller GM, Pittock SJ. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 Nov; 68(5):757-61.
    View PubMed
  71. Fischer PR, Sandroni P, Pittock SJ, Porter CB, Lehwald LM, Raj SR. Isolated sympathetic failure with autoimmune autonomic ganglionopathy. Pediatr Neurol. 2010 Oct; 43(4):287-90.
    View PubMed
  72. Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, Drubach DA, Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi JE, Pittock SJ. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010 Oct; 85(10):881-97.
    View PubMed
  73. Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010 Sep; 67(9):1109-15.
    View PubMed
  74. Pittock SJ, Debruyne J, Krecke KN, Giannini C, van den Ameele J, De Herdt V, McKeon A, Fealey RD, Weinshenker BG, Aksamit AJ, Krueger BR, Shuster EA, Keegan BM. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2010 Sep; 133(9):2626-34. Epub 2010 Jul 17.
    View PubMed
  75. Mateen FJ, Keegan BM, Krecke K, Parisi JE, Trenerry MR, Pittock SJ. Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. J Neurol Neurosurg Psychiatry. 2010 Jun; 81(6):619-22. Epub 2010 Feb 22.
    View PubMed
  76. Chamberlain JL, Pittock SJ, Oprescu AM, Dege C, Apiwattanakul M, Kryzer TJ, Lennon VA. Peripherin-IgG association with neurologic and endocrine autoimmunity. J Autoimmun. 2010 Jun; 34(4):469-77. Epub 2010 Jan 12.
    View PubMed
  77. Apiwattanakul M, McKeon A, Pittock SJ, Kryzer TJ, Lennon VA. Eliminating false-positive results in serum tests for neuromuscular autoimmunity. Muscle Nerve. 2010 May; 41(5):702-4.
    View PubMed
  78. McKeon A, Apiwattanakul M, Lachance DH, Lennon VA, Mandrekar JN, Boeve BF, Mullan B, Mokri B, Britton JW, Drubach DA, Pittock SJ. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010 Mar; 67(3):322-9. Epub 2010 Jan 11.
    View PubMed
  79. Kraichely RE, Farrugia G, Pittock SJ, Castell DO, Lennon VA. Neural autoantibody profile of primary achalasia. Dig Dis Sci. 2010 Feb; 55(2):307-11. Epub 2009 Jun 05.
    View PubMed
  80. Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):109-11.
    View PubMed
  81. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010 Jan; 9(1):55-66. Epub 2009 Nov 27.
    View PubMed
  82. Lim SY, Mason WP, Young NP, Chen R, Bower JH, McKeon A, Pittock SJ, Lang AE. Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodies. Arch Neurol. 2009 Oct; 66(10):1285-7.
    View PubMed
  83. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol. 2009 Sep; 66(9):1164-7.
    View PubMed
  84. McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol. 2009 Sep; 66(9):1134-8.
    View PubMed
  85. Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009 Sep; 66(9):1128-33.
    View PubMed
  86. Magana SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol. 2009 Aug; 66(8):964-6.
    View PubMed
  87. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol. 2009 Jun; 66(6):735-41.
    View PubMed
  88. Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009 Feb 24; 72(8):712-7.
    View PubMed
  89. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol. 2009 Feb; 66(2):268-71.
    View PubMed
  90. McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve. 2009 Jan; 39(1):87-90.
    View PubMed
  91. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008 Oct 27; 205(11):2473-81. Epub 2008 Oct 06.
    View PubMed
  92. Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol. 2008 Oct; 65(10):1341-6.
    View PubMed
  93. Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2008 Sep; 6(9):988-92. Epub 2008 Jul 02.
    View PubMed
  94. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 Jul 8; 71(2):93-100. Epub 2008 May 28.
    View PubMed
  95. Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, Konig F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Bruck W. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008 Jul; 131(Pt 7):1759-75. Epub 2008 Jun 05.
    View PubMed
  96. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008 Jun 3; 70(23):2197-200. Epub 2008 Apr 23.
    View PubMed
  97. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008 May 13; 70(20):1883-90.
    View PubMed
  98. Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol. 2008 May; 65(5):629-32.
    View PubMed
  99. Keegan BM, Pittock SJ, Lennon VA. Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol. 2008 Apr; 63(4):531-4.
    View PubMed
  100. Pittock SJ. Neuromyelitis optica: a new perspective. Semin Neurol. 2008 Feb; 28(1):95-104.
    View PubMed
  101. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008 Jan 29; 70(5):344-52. Epub 2007 Dec 19
    View PubMed
  102. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008 Jan; 65(1):78-83.
    View PubMed
  103. Pittock SJ, Rodriguez M. Benign multiple sclerosis: a distinct clinical entity with therapeutic implications. Curr Top Microbiol Immunol. 2008; 318:1-17.
    View PubMed
  104. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007 Dec 11; 69(24):2221-31. Epub 2007 Oct 10.
    View PubMed
  105. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep; 6(9):805-15.
    View PubMed
  106. McKeon A, Pittock SJ, Glass GA, Josephs KA, Bower JH, Lennon VA, Ahlskog JE. Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol. 2007 Sep; 64(9):1318-22.
    View PubMed
  107. McKeon A, Ozelius LJ, Hardiman O, Greenway MJ, Pittock SJ. Heterogeneity of presentation and outcome in the Irish rapid-onset dystonia-parkinsonism kindred. Mov Disord. 2007 Jul 15; 22(9):1325-7.
    View PubMed
  108. Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. J Neuroimmunol. 2007 Jul; 187(1-2):126-38. Epub 2007 May 21.
    View PubMed
  109. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 May; 130(Pt 5):1194-205.
    View PubMed
  110. Pittock SJ, Lucchinetti CF. The pathology of MS: new insights and potential clinical applications. Neurologist. 2007 Mar; 13(2):45-56.
    View PubMed
  111. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007 Feb 20; 68(8):603-5.
    View PubMed
  112. Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler. 2007 Jan; 13(1):7-16.
    View PubMed
  113. Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol. 2006 Oct; 63(10):1398-400.
    View PubMed
  114. Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006 Sep; 81(9):1207-14.
    View PubMed
  115. Pittock SJ, Lucchinetti CF. Inflammatory transverse myelitis: evolving concepts. Curr Opin Neurol. 2006 Aug; 19(4):362-8.
    View PubMed
  116. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 Jul; 63(7):964-8.
    View PubMed
  117. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May 23; 66(10):1485-9.
    View PubMed
  118. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 Mar; 59(3):566-9.
    View PubMed
  119. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 Mar; 63(3):390-6.
    View PubMed
  120. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb; 63(2):197-202.
    View PubMed
  121. Pittock SJ, Rodriguez M. Disability in multiple sclerosis. Is MS a more benign condition than previously supposed? Cuadernos de Esclerosis Multiple. 2006.
  122. Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers. 2006; 22(4):197-206.
    View PubMed
  123. Weinshenker B, Wingerchuk D, Pittock S, Lucchinetti C, Lennon V. A Secondary Progressive Clinical Course is Uncommon in Neuromyelitis Optica. Neurology. 2006.
    View PubMed
  124. Lin F, Murphy R, White B, Kelly J, Feighery C, Doyle R, Pittock S, Moroney J, Smith O, Livingstone W, Keenan C, Jackson J. Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation. Lupus. 2006; 15(2):87-93.
    View PubMed
  125. Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, Lassmann H, Parisi JE, Scheithauer BW, Rodriguez M, Weinshenker BG, Lucchinetti CF. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry. 2005 Dec; 76(12):1693-7.
    View PubMed
  126. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 Aug 15; 202(4):473-7. Epub 2005 Aug 08.
    View PubMed
  127. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Killmann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005 Jul; 58(1):96-107.
    View PubMed
  128. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 Dec 11-17; 364(9451):2106-12.
    View PubMed
  129. Pittock SJ, McClelland RL, Mayr WT, Rodriguez M, Matsumoto JY. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord. 2004 Dec; 19(12):1482-5.
    View PubMed
  130. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Annals of Neurology. 2004 Nov; 56(5):715-9.
    View PubMed
  131. Pittock SJ, Weinshenker BG, Wijdicks EFM. Mechanical ventilation and tracheostomy in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004 Sep; 75(9):1331-3.
    View PubMed
  132. Meldrum D, Pittock SJ, Hardiman O, Ni Dhuill C, O'Regan M. Recovery of the upper limb post ischaemic stroke and the predictive value of the Orpington Prognostic Score. Clin Rehabil. 2004 Sep; 18(6):694-702.
    View PubMed
  133. Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, Rodriguez M. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 2004 Aug; 56(2):303-6.
    View PubMed
  134. Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord. 2004 Jun; 19(6):695-9.
    View PubMed
  135. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. Quality of life is favorable for most patients with multiple sclerosis-a population-based cohort study. Arch Neurol. 2004 May; 61(5):679-86.
    View PubMed
  136. Kantarci OH, Hebrink DD, Achenbach SJ, Pittock SJ, Altintas A, Schaefer-Klein JL, Atkinson EJ, de Andrade M, McMurray CT, Rodriguez M, Weinshenker BG. Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology. 2004 Mar 9; 62(5):811-4.
    View PubMed
  137. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology. 2004 Feb 24; 62(4):601-6.
    View PubMed
  138. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Weinshenker BG, Rodriguez M. Change in MS-related disability in a population-based cohort - A 10-year follow-up study. Neurology. 2004 Jan 13; 62(1):51-9.
    View PubMed
  139. Balding J, Livingstone WJ, Pittock SJ, et al. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. IJMS. 2004; 173(4):200-3.
    View PubMed
  140. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology. 2003 Nov 25; 61(10):1373-7.
    View PubMed
  141. Rabinstein AA, Pittock SJ, Miller GM, Schindler JJ, Wijdicks EFM. Pseudosubarachnoid haemorrhage in subdural haematoma. J Neurol Neurosurg Psychiatry. 2003 Aug; 74(8):1131-2.
    View PubMed
  142. Pittock SJ, Meldrum D, Ni Dhuill C, Hardiman O, Moroney JT. The Orpington Prognostic Scale within the first 48 hours of admission as a predictor of outcome in ischemic stroke. J Stroke Cerebrovasc Dis. 2003 Jul-Aug; 12(4):175-81.
    View PubMed
  143. Pittock SJ, Meldrum D, Hardiman O, Deane C, Dunne P, Hussey A, Gorman M, Moroney JT. Patient and hospital delays in acute ischaemic stroke in a Dublin teaching hospital. Ir Med J. 2003 Jun; 96(6):167-8 170-1.
    View PubMed
  144. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Ann Neurol 2003 May; 53(5):580-7.
    View PubMed
  145. Pittock SJ, Rabinstein AA, Edwards BS, Wijdicks EFM. OKT3 neurotoxicity presenting as akinetic mutism. Transplantation. 2003 Apr 15; 75(7):1058-60.
    View PubMed
  146. Pittock SJ, Meldrum D, Hardiman O, Thornton J, Brennan P, Moroney JT. The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2003 Jan; 12(1):1-7.
    View PubMed
  147. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis. 2003; 15(4):289-300.
    View PubMed
  148. Pittock SJ, Meldrum D, Hardiman O. The "spray can" sign: validation of a clinical observation in chronic inflammatory demyelinating polyneuropathy. Arch Neurol. 2002 Oct; 59(10):1637-40.
    View PubMed
  149. Pittock SJ. Unilateral osteoarthritis--"the working hand". N Engl J Med. 2002 Mar 7; 346(10):e3.
    View PubMed
  150. Pittock SJ, Payne TA, Harper CM. Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. Mayo Clin Proc. 2002 Mar; 77(3):291-4.
    View PubMed
  151. Pittock SJ, Rodriguez M, Wijdicks EF. Rapid weaning from mechanical ventilator in acute cervical cord multiple sclerosis lesion after steroids. Anesth Analg. 2001 Dec; 93(6):1550-1, table of contents.
    View PubMed
  152. Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol. 2001 Nov; 8(6):559-65.
    View PubMed
  153. Henderson RD, Pittock SJ, Piepgras DG, Wijdicks EF. Acute spontaneous spinal epidural hematoma. Arch Neurol. 2001 Jul; 58(7):1145-6.
    View PubMed
  154. Pittock SJ, Hardiman O, Goode B, Moroney JT. Evaluation of stroke management in an Irish university teaching hospital: the Royal College of Physicians stroke audit package. Ir J Med Sci. 2001 Jul-Sep; 170(3):163-8.
    View PubMed
  155. Pittock SJ, Moroney JT, Alexander M, Brennan P, Moorhouse D. Traumatic bilateral carotid dissection with concomitant cerebral infarction. J Emerg Med. 2001 Jan; 20(1):33-8.
    View PubMed
  156. Pittock SJ, Joyce C, O’Keane V, Hugle B, Hardiman MO, Brett F, Green AJ, Barton DE, King MD, Webb DW. Rapid onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology. 2000 Oct 10; 55(7):991-5.
    View PubMed
  157. Ni Dhuill CM, Fox GB, Pittock SJ, O’Connell AW, Murphy KJ, Regan CM. Polysialylated neural cell adhesion molecule expression in the dentate gyrus of the human hippocampal formation from infancy to old age. J Neurosci Res. 1999 Jan 1; 55(1):99-106.
    View PubMed